BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis

QR Code

BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis

None

Saved in:

Bibliographic Details
Main Authors:	Hardingham, Jennifer E., Chua, Ann, Wrin, Joseph W., Shivasami, Aravind, Kanter, Irene, Tebbutt, Niall C., Price, Timothy J.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Life Sciences
Online Access:	https://www.intechopen.com/chapters/37264
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers
by: Pawel Sadlecki, et al.
Published: (2017-05-01)

BRAF V600E Mutated Gene Variant as a Circulating Molecular Marker in Metastatic Melanoma Patients
by: Vallacchi, Viviana, et al.
Published: (2011)

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study
by: Clara Mayo de las Casas, et al.
Published: (2025-01-01)

Sialadenoma papilliferum-like intraductal papillary tumor of the mandible with BRAF V600E mutation: A rare case report
by: Sak Lee, et al.
Published: (2025-07-01)

Use of BRAF V600E as a Molecular Marker in Aggressive Colorectal Cancer
by: Bethy S Hernowo, et al.
Published: (2016-05-01)

Use of BRAF V600E as a Molecular Marker in Aggressive Colorectal Cancer
by: Bethy S Hernowo, et al.
Published: (2016-05-01)

Transsulfuration Reprogramming: A Metabolic Driver of BRAF‐V600E Resistance in Melanoma
by: Juntong Chen, et al.
Published: (2025-06-01)

DETECTION OF SOMATIC MUTATIONS IN THE BRAF GENE BY PYROSEQUENCING
by: O. P. Dribnokhodova, et al.
Published: (2021-10-01)

Eosinophilic Cells as a Distinct Morphological Feature in <i>BRAF<sup>V600E</sup></i>-Mutated Ovarian Serous Borderline Tumors
by: Alina Badlaeva, et al.
Published: (2025-06-01)

Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable <i>BRAF</i> V600-mutated metastatic melanoma in Russia
by: N. A. Avxentyev, et al.
Published: (2023-11-01)

Axillary cutaneous metastasis of colon cancer with microsatellite instability-high and BRAF V600E mutation treated with curative-intent surgery: a case report
by: Daisuke Yamai, et al.
Published: (2023-11-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01)

TREATMENT OF <em>BRAF</em><sup>V600E</sup> POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT
by: P. A. Nikiforovich, et al.
Published: (2020-10-01)

COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK Pathway
by: Ada Ndoja, et al.
Published: (2025-06-01)

Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells
by: Girolamo Spagnoletti, et al.
Published: (2018-04-01)

BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis.
by: David S Nelson, et al.
Published: (2019-01-01)

ANALYSIS OF MUTATIONS IN KRAS AND BRAF GENES IN COLORECTAL CANCER IN RUSSIAN PATIENTS
by: E. E. Pisareva, et al.
Published: (2016-07-01)

THE SEARCH FOR GENE MUTATIONS AT CYSTIC FIBROSIS IN CHILDREN BY THE METHOD OF HIGH-RESOLUTION MELTING ANALYSIS
by: M. Y. Donnikov, et al.
Published: (2019-02-01)

THE ROLE OF BRAF MUTATION STATUS IN SURGICAL TREATMENT OF WELL-DIFFERENTIATED THYROID CANCER
by: A. P. Polyakov, et al.
Published: (2017-04-01)

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
by: O. I. Kit, et al.
Published: (2016-06-01)

Investigating therapeutic efficacy of dacarbazine and temozolomide, alone and in combination with BRAF(V600E) siRNA in A375 human melanoma cell line
by: Fatemeh Tabandeh, et al.
Published: (2025-06-01)

Clinical impact of first-line therapeutic strategies in BRAF V600E-mutant metastatic colorectal cancer: real-world evidence and prognostic insight
by: Chia-Chang Yeh, et al.
Published: (2025-07-01)

The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01)

Site‐Specific Mutations on KRAS, NRAS, and BRAF Corelate With the Frequency of ctDNA in Colorectal Cancer
by: Fumihiro Yoshimura, et al.
Published: (2025-07-01)

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.
by: Gholamreza Safaee Ardekani, et al.
Published: (2012-01-01)

Combined target therapy (dabrafenib and trametinib) in the treatment of metastatic <i>BRAF</i><sup> V600E </sup>-positive anaplastic thyroid cancer: clinical cases
by: S. S. Lebedev, et al.
Published: (2025-05-01)

BRAF mutations in patients with non-small cell lung cancer: a systematic review and meta-analysis.
by: Dong Chen, et al.
Published: (2014-01-01)

BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature
by: Marianna Peroni, MD, et al.
Published: (2025-08-01)

Cutaneous metastasis of cecum cancer with MSI-high and BRAFV600E mutation: a case report
by: Kosuke Yunoki, et al.
Published: (2021-08-01)

Distribution of BRAFV600E mutation in cytological samples of thyroid nodules and its clinical application value
by: WANG Lei, JIN Jingjing, YU Na, XIAO Li
Published: (2025-04-01)

Identifying a wide range of mutations in the <i>BRAF</i> gene for prescribing targeted drugs for melanoma treatment
by: A. N. Toropovskiy, et al.
Published: (2023-03-01)

KIT, NRAS and BRAF mutations in head and neck (upper aerodigestive tract) mucosal melanoma (a study of 21 cases)
by: A. V. Ignatova, et al.
Published: (2017-04-01)

BRAF and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone B-cell lymphoma
by: I. A. Yakutik, et al.
Published: (2016-03-01)

INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01)

Resistance to MAPK Pathway Inhibition in <i>BRAF</i>-V600E Mutant Colorectal Cancer Can Be Overcome with Insulin Receptor/Insulin-like Growth Factor-1 Receptor Inhibitors
by: Layla El Bouazzaoui, et al.
Published: (2025-06-01)

BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.
by: Dong Chen, et al.
Published: (2014-01-01)

Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption.
by: Rachael Thomas, et al.
Published: (2023-04-01)

Highly sensitive scanning of gene mutations: TaqMan probes as blocking agents
by: I. V. Botezatu, et al.
Published: (2016-06-01)

Deep learning for enhancement of low-resolution and noisy scanning probe microscopy images
by: Samuel Gelman, et al.
Published: (2025-07-01)

Evaluation of BRAF and KRAS Gene Expression in Nasal Polyposis
by: Gül Özbilen Acar, et al.
Published: (2025-06-01)